Patterson Companies (PDCO) 8-K Patterson Companies Reports Record Fiscal 2015 Fourth Quarter Operating Results

Exhibit 99.1

Patterson Companies Reports Record Fiscal 2015 Fourth Quarter Operating Results

• Sales totaled $1.1 billion, up 6.7 percent on constant currency basis, with adjusted earnings per diluted share of $0.68

• Dental sales expanded by 10.3 percent on a constant currency basis, reflecting strong equipment sales

• Full fiscal-year sales rose 8.7 percent on a constant currency basis, with adjusted earnings per share of $2.27

• Company provides adjusted earnings guidance range for fiscal year 2016

St. Paul, Minn. — May 21, 2015 —Patterson Companies, Inc. (Nasdaq: PDCO) today reported that consolidated sales totaled $1.1 billion (see attached Sales Summary for further details) in its fiscal fourth quarter ended April 25, 2015; 4.2 percent higher than fiscal 2014. Reported net income totaled $64.5 million, or $0.65 per diluted share, compared to $55.7 million, or $0.55 per diluted share during the same period last fiscal year. After adjusting for one-time transaction costs related to the pending acquisition of Animal Health International and the potential sale of Patterson Medical, fourth quarter fiscal 2015 earnings per diluted share were $0.68.

“Executing on our strategic plan and focusing on operational discipline enabled Patterson to close fiscal 2015 with healthy contributions from all three of our businesses,” said Scott Anderson, chairman and chief executive officer. “We are encouraged by the momentum we are seeing in all of our business units. As we work to complete the acquisition of Animal Health International and the potential sale of our Medical unit, we are confident that the transformation we are pursuing for Patterson will lead to long-term growth and success.”

Patterson Dental

Sales for Patterson Dental, which accounts for approximately 59 percent of total sales, increased to $679.1 million, up 10.3 percent on a constant currency basis, from the year-earlier period. Also, on a constant currency basis, sales by category versus the prior-year quarter were as follows:

• Dental equipment and software improved 23.3 percent led by strong CEREC CAD/CAM and digital technology sales;

• Consumable dental supplies increased 3.3 percent; and

• Other services and products, consisting primarily of technical service, parts and labor, software support services and artificial teeth, climbed 6.0 percent.

Commented Anderson, “We are pleased with the growth and share gains in technology-oriented sales, driven by Patterson’s industry-leading sales, technical service and after-sales support. We believe that dentists’ willingness to invest in technology affirms the trend toward dental-office digitization. Our technology and expanding core dental equipment offerings, complemented by Patterson’s high-touch service, position us well to capitalize on stable-to-steadily improving market dynamics.”

Patterson Veterinary

Sales for Patterson Veterinary, the company’s second largest business, increased to $356.0 million, or up 2.7 percent on a constant currency basis. For veterinary sales by category, again on a constant currency basis, versus the year-ago quarter:

• Consumable sales rose 1.7 percent;

• Equipment sales increased 31.8 percent; and

• Sales of other services and products, consisting primarily of technical service, parts and labor, and software support services, were up 2.5 percent.

Anderson continued, “Patterson Veterinary, which represented about one-third of our total sales, reported growth in the fiscal fourth quarter as we continue to transition to a new diagnostic manufacturer relationship. We believe our recently announced agreement to acquire Animal Health International will strengthen the scale and market position of Patterson Veterinary, expanding our presence in production and companion animal markets.”

On May 4, 2015, Patterson Companies announced a definitive agreement to acquire Animal Health International, Inc., a leading production animal health distribution company in the United States. This acquisition will more than double the size of Patterson’s veterinary business. The combined unit will offer a range of products and services to customers in the United States, Canada and the United Kingdom.

Patterson Medical

Sales for Patterson Medical, the company’s rehabilitation supply and equipment business, totaled $113.8 million in the fiscal 2015 fourth quarter, up 3.7 percent, excluding currency and prior-year divestiture impacts. Consolidated sales of Patterson Medical currently represent approximately 10 percent of total company sales.

Anderson said, “Earlier this month, we announced the potential sale of our Medical unit. Our initiatives to improve the performance of Patterson Medical were again demonstrated as we posted sales gains for the fourth consecutive quarter. We believe that Patterson Medical will flourish under a new owner that can focus on driving growth in the rehabilitation space.”

Share Repurchases and Dividends

For the fiscal 2015 year, Patterson repurchased approximately 1.2 million shares of its outstanding common stock, with a value of $47.5 million, leaving approximately 21 million shares for repurchase under the current authorization. The company also increased its dividend in the fiscal fourth quarter by 10 percent to $0.22 per share and paid $21.5 million in cash dividends to shareholders in the period. The company paid $81.8 million in dividend payments for fiscal year 2015.

Full-Year Results

Consolidated sales for the full fiscal 2015 year totaled $4.4 billion, up 8.7 percent on a constant currency basis from $4.1 billion in fiscal 2014. Adjusted net income was $226.2 million, or $2.27 per diluted share (adjusted for $0.03 per diluted share of one-time transaction costs related to the acquisition of Animal Health International and the potential sale of Patterson Medical), compared to adjusted net income of $213.9 million, or $2.10 per diluted share, in fiscal 2014 (adjusted for $0.13 per share of costs for the Patterson Medical restructuring).

Business Outlook

Anderson concluded, “We begin fiscal 2016 with optimism and momentum. Our previously announced agreement to acquire Animal Health International, along with the potential divestiture of our Medical unit, have the potential to transform Patterson Companies and our growth profile. As we move into the new fiscal year, we are encouraged by the stable-to-strengthening demand across all of our businesses. We are establishing our adjusted fiscal 2016 earnings guidance in the range of $2.40-$2.50 per diluted share.”

The fiscal 2016 annual financial outlook and adjusted earnings guidance:

• Assumes stable North American and international markets – conditions similar to fiscal 2015

• Includes the impact of an extra week in fiscal 2016 compared to the previous year

• Excludes the following:

• Approximately $0.05 of one-time training costs related to the company’s enterprise resource planning implementation

• The impact from additional share repurchases that may occur

• The impact of the Animal Health International acquisition and potential Medical divestiture

Fourth Quarter and Full Fiscal Year Reconciliation

The following non-GAAP table is provided to adjust reported net income for the impact of the costs associated with restructuring the medical segment and one-time transaction costs related to the pending acquisition of Animal Health International and the potential sale of Patterson Medical. Management believes that the adjusted income amounts provide a helpful representation of the company’s current quarter performance.

(Dollars in thousands, except EPS)
	Three Months Ended				Twelve Months Ended
	April 25, 2015		April 26, 2014		April 25, 2015		April 26, 2014
Net Income - reported	$	64,518	$	55,670	$	223,261	$	200,612
Restructuring costs		—		5,701		—		13,267
One-time transaction costs		2,894		—		2,894		—
Net Income - adjusted	$	67,412	$	61,371	$	226,155	$	213,879
Diluted Earnings Per Share - reported	$	0.65	$	0.55	$	2.24	$	1.97
Restructuring costs		—		0.06		—		0.13
One-time transaction costs		0.03		—		0.03		—
Diluted Earnings Per Share - adjusted	$	0.68	$	0.61	$	2.27	$	2.10

Fourth Quarter Conference Call and Replay

Patterson’s fourth quarter earnings conference call will start at 10 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on Patterson’s website. A replay of the fourth quarter conference call can be heard for one week at 888-203-1112 and by providing the Conference ID 1982881, when prompted.

About Patterson Companies, Inc.

Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.

Dental Market

As Patterson’s largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

Veterinary Market

Patterson Veterinary is a leading distributor in the U.S. and U.K. of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals predominantly to companion-pet veterinary clinics.

Rehabilitation Market

Patterson Medical is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. Any statements made in this press release about the Company’s future financial conditions, results of operations, expectations, plans, or prospects, including the information under the heading “Business Outlook”, constitute forward-looking statements. Forward-looking statements also include those preceded or followed by the words “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “should,” “targets” and/or similar expressions. These forward-looking statements are based on the Company’s current estimates and assumptions and, as such, involve uncertainty and risk. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those contemplated by the forward-looking statements because of a number of factors, including the factors described in Item 1A of the Company’s most recent Annual Report on Form 10-K, which factors are incorporated herein by reference. Any forward-looking statement in this release speaks only as of the date in which it is made. Except to the extent required under the federal securities laws, the Company does not intend to update or revise the forward-looking statements.

For additional information contact:

Ann B. Gugino

Vice President & CFO

651-686-1600

Source: Patterson Companies, Inc.

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended						Twelve Months Ended
	April 25, 2015			April 26, 2014			April 25, 2015			April 26, 2014
Net sales	$	1,148,854		$	1,102,077		$	4,375,020		$	4,063,715
Gross profit		333,600			315,868			1,238,206			1,198,278
Operating expenses		226,904			223,267			864,779			852,522
Operating income		106,696			92,601			373,427			345,756
Other expense, net		(7,511	)		(7,479	)		(30,756	)		(32,844	)
Income before taxes		99,185			85,122			342,671			312,912
Income taxes		34,667			29,452			119,410			112,300
Net income	$	64,518		$	55,670		$	223,261		$	200,612
Earnings per share:
Basic	$	0.65		$	0.56		$	2.26		$	1.99
Diluted	$	0.65		$	0.55		$	2.24		$	1.97
Shares:
Basic		98,981			99,707			98,989			100,727
Diluted		99,677			100,684			99,694			101,643
Dividends declared per common share	$	0.22		$	0.20		$	0.82		$	0.68
Gross margin - adjusted		29.0	%		28.7	%		32.2	%		32.2	%
NVS		—			—			(3.9	)		(2.6	)
Medical restructuring		—			—			—			(0.1	)
Gross margin - reported		29.0	%		28.7	%		28.3	%		29.5	%
Operating expenses as a % of net sales - adjusted		19.3	%		19.7	%		22.5	%		22.6	%
NVS		—			—			(2.8	)		(1.9	)
One-time transaction costs		0.4			—			0.1			—
Medical restructuring		—			0.6			—			0.3
Operating expenses as a % of net sales - reported		19.7	%		20.3	%		19.8	%		21.0	%
Operating income as a % of net sales - adjusted		9.7	%		9.0	%		9.7	%		9.6	%
NVS		—			—			(1.1	)		(0.7	)
One-time transaction costs		(0.4	)		—			(0.1	)		—
Medical restructuring		—			(0.6	)		—			(0.4	)
Operating income as a % of net sales - reported		9.3	%		8.4	%		8.5	%		8.5	%
Effective tax rate - adjusted		35.1	%		33.7	%		35.2	%		35.2	%
NVS		—			—			(0.4	)		(0.3	)
One-time transaction costs		(0.1	)		—			—			—
Medical restructuring		—			0.9			—			1.0
Effective tax rate - reported		35.0	%		34.6	%		34.8	%		35.9	%

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

	April 25, 2015		April 26, 2014
	(Unaudited)
ASSETS
Current assets:
Cash and short-term investments	$	400,632	$	305,683
Receivables		644,139		607,580
Inventory		456,687		436,463
Prepaid expenses and other current assets		71,767		65,991
Total current assets		1,573,225		1,415,717
Property and equipment, net		226,805		204,939
Goodwill and other intangible assets		1,036,928		1,067,583
Investments and other		110,748		176,438
Total assets	$	2,947,706	$	2,864,677
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	349,635	$	342,056
Other accrued liabilities		228,050		201,407
Total current liabilities		577,685		543,463
Long-term debt		725,000		725,000
Other non-current liabilities		130,898		124,550
Total liabilities		1,433,583		1,393,013
Stockholders’ equity		1,514,123		1,471,664
Total liabilities and stockholders’ equity	$	2,947,706	$	2,864,677

PATTERSON COMPANIES, INC.

SALES SUMMARY

(Dollars in thousands)

(Unaudited)

	April 25, 2015		April 26, 2014		Total Sales Growth			Foreign Exchange Impact			Constant Currency Growth
Three Months Ended
Consolidated net sales
Consumable and printed products1	$	770,282	$	774,286		(0.5	)%		(2.8	)%		2.3	%
Equipment and software1		292,414		244,367		19.7			(1.8	)		21.5
Other		86,158		83,424		3.3			(1.4	)		4.7
Total	$	1,148,854	$	1,102,077		4.2	%		(2.5	)%		6.7	%
Dental supply
Consumable and printed products1	$	353,597	$	345,932		2.2	%		(1.1	)%		3.3	%
Equipment and software1		252,859		207,750		21.7			(1.6	)		23.3
Other		72,624		69,166		5.0			(1.0	)		6.0
Total	$	679,080	$	622,848		9.0	%		(1.3	)%		10.3	%
Veterinary supply
Consumable and printed products	$	332,915	$	342,294		(2.7	)%		(4.4	)%		1.7	%
Equipment and software		15,504		11,777		31.6			(0.2	)		31.8
Other		7,562		7,768		(2.7	)		(5.2	)		2.5
Total	$	355,981	$	361,839		(1.6	)%		(4.3	)%		2.7	%
Rehabilitation supply
Consumable and printed products	$	83,769	$	86,060		(2.7	)%		(3.1	)%		0.4	%
Equipment and software		24,052		24,840		(3.2	)		(4.0	)		0.8
Other		5,972		6,490		(8.0	)		(1.6	)		(6.4	)
Total	$	113,793	$	117,390		(3.1	)%		(3.2	)%		0.1	%
Twelve Months Ended
Consolidated net sales
Consumable and printed products1	$	3,083,113	$	2,810,491		9.7	%		(1.1	)%		10.8	%
Equipment and software1		958,067		940,088		1.9			(0.9	)		2.8
Other		333,840		313,136		6.6			(0.7	)		7.3
Total	$	4,375,020	$	4,063,715		7.7	%		(1.0	)%		8.7	%
Dental supply
Consumable and printed products1	$	1,355,982	$	1,323,378		2.5	%		(0.8	)%		3.3	%
Equipment and software1		818,342		795,132		2.9			(0.9	)		3.8
Other		279,971		263,586		6.2			(0.7	)		6.9
Total	$	2,454,295	$	2,382,096		3.0	%		(0.8	)%		3.8	%
Veterinary supply
Consumable and printed products	$	1,380,427	$	1,134,932		21.6	%		(1.6	)%		23.2	%
Equipment and software		46,671		44,020		6.0			(0.1	)		6.1
Other		29,472		24,093		22.3			(1.9	)		24.2
Total	$	1,456,570	$	1,203,045		21.1	%		(1.5	)%		22.6	%
Rehabilitation supply
Consumable and printed products	$	346,704	$	352,181		(1.6	)%		(0.5	)%		(1.1	)%
Equipment and software		93,054		100,936		(7.8	)		(1.3	)		(6.5	)
Other		24,397		25,457		(4.2	)		(0.4	)		(3.8	)
Total	$	464,155	$	478,574		(3.0	)%		(0.7	)%		(2.3	)%

¹ Certain products were reclassed from equipment to consumables in current and prior periods

PATTERSON COMPANIES, INC.

SUPPLEMENTARY FINANCIAL DATA

(In thousands)

(Unaudited)

	Three Months Ended						Twelve Months Ended
	April 25, 2015			April 26, 2014			April 25, 2015			April 26, 2014
Operating income
Dental supply	$	70,637		$	67,292		$	249,575		$	249,138
Veterinary supply		16,483			16,680			56,670			49,855
Rehabilitation supply		19,576			8,629			67,182			46,763
	$	106,696		$	92,601		$	373,427		$	345,756
Other (expense) income, net
Interest income	$	952		$	1,090		$	4,864		$	4,982
Interest expense		(7,868	)		(9,132	)		(33,693	)		(35,713	)
Other		(595	)		563			(1,927	)		(2,113	)
	$	(7,511	)	$	(7,479	)	$	(30,756	)	$	(32,844	)

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Twelve Months Ended
	April 25, 2015			April 26, 2014
Operating activities:
Net income	$	223,261		$	200,612
Depreciation & amortization		51,330			49,986
Non-cash employee based compensation		26,485			20,018
Change in assets and liabilities, net of acquired		(38,385	)		(74,780	)
Net cash provided by operating activities		262,691			195,836
Investing activities:
Additions to property and equipment, net of disposals		(62,945	)		(40,387	)
Acquisitions and equity investments		(10,515	)		(145,815	)
Proceeds from sale		46,369			6,546
Purchase of investments		(543	)		(99,672	)
Other investing activity		18,035			(4,436	)
Net cash used in investing activities		(9,599	)		(283,764	)
Financing activities:
Dividends paid		(81,760	)		(85,657	)
Share repurchases		(47,539	)		(96,486	)
Payment on revolver		(130,000	)		(135,000	)
Draw on revolver		130,000			135,000
Settlement of swap		(29,003	)		—
Retirement of long-term debt		(250,000	)		—
Proceeds from issuance of long-term debt		250,000			—
Other financing activities		7,367			21,942
Net cash used in financing activities		(150,935	)		(160,201	)
Effect of exchange rate changes on cash		(19,805	)		7,809
Net increase (decrease) in cash and cash equivalents	$	82,352		$	(240,320	)

# # #